Author Grützmann, R.
-
2018 | Journal Article
Neoadjuvant rectal score as individual-level surrogate for disease-free survival in rectal cancer in the CAO/ARO/AIO-04 randomized phase III trial
Fokas, E.; Fietkau, R.; Hartmann, A.; Hohenberger, W.; Grützmann, R.; Ghadimi, M. & Liersch, T. et al. (2018)
Annals of Oncology, 29(7) pp. 1521-1527. DOI: https://doi.org/10.1093/annonc/mdy143
Details DOI
-
2018 | Journal Article
OC-0278: NAR score as surrogate for disease-free survival in the CAO/ARO/AIO-04 phase 3 rectal cancer trial
Fokas, E.; Fietkau, R.; Hartmann, A.; Hohenberger, W.; Grützmann, R.; Ghadimi, M. & Liersch, T. et al. (2018)
Radiotherapy and Oncology, 127 pp. S142. DOI: https://doi.org/10.1016/S0167-8140(18)30588-7
Details DOI
-
2019 | Journal Article
OC-0501 Chemo-RT plus induction or consolidation chemotherapy for rectal cancer: a randomised phase 2 trial
Fokas, E.; Allgäuer, M.; Polat, B.; Klautke, G.; Grabenbauer, G.; Fietkau, R. & Kuhnt, T. et al. (2019)
Radiotherapy and Oncology, 133 pp. S257-S258. DOI: https://doi.org/10.1016/S0167-8140(19)30921-1
Details DOI
-
2019 | Journal Article |
Consensus in determining the resectability of locally progressed pancreatic ductal adenocarcinoma – results of the Conko-007 multicenter trial
Wittel, U. A.; Lubgan, D.; Ghadimi, M. ; Belyaev, O.; Uhl, W.; Bechstein, W. O. & Grützmann, R. et al. (2019)
BMC Cancer, 19(1). DOI: https://doi.org/10.1186/s12885-019-6148-5
Details DOI
-
2020 | Journal Article |
R0 resection following chemo (radio)therapy improves survival of primary inoperable pancreatic cancer patients. Interim results of the German randomized CONKO-007± trial
Fietkau, R.; Grützmann, R.; Wittel, U. A.; Croner, R. S.; Jacobasch, L.; Neumann, U. P. & Reinacher-Schick, A. et al. (2020)
Strahlentherapie und Onkologie, 197(1) pp. 8-18. DOI: https://doi.org/10.1007/s00066-020-01680-2
Details DOI